63, No. 7, 2014 ACC/AHA/SCAI/AMA-PCPI/NCQA February 25, 2014:722 45 representative. The writing committee had representation from the American Association of Cardiovascular and Pulmonary Rehabilitation, Mended Hearts, SCAI, and the Society for Thoracic Surgeons (STS). 1.3. Disclosure of Relationships With Industry and Other Entities The ACC/AHA Task Force on Performance Measures makes every effort to avoid actual, potential, or perceived con icts of interest that could arise as a result of re- lationships with industry or other entities (RWI). Detailed information on the ACC/AHA policy on RWI can be found at http://www.cardiosource.org/Science-And-Quality/ Practice-Guidelines-and-Quality-Standards/Relationships- With-Industry-Policy.aspx. All members of the writing committee, as well as those selected to serve as peer re- viewers of this document, were required to disclose all current relationships and those existing within the 12 months before the initiation of this writing effort. ACC/ AHA policy also requires that the writing committee co- chairs and at least 50% of the writing committee have no relevant RWI. Table 1. 2013 ACC/AHA/SCAI/AMA-PCPI/NCQA Percutaneous Coronary Intervention Measurement Set Measure Description* 1. Comprehensive Documentation of Indications for PCIy Percentage of patients aged 18 years for whom PCI is performed with comprehensive documentation of the procedure. This documentation includes, at a minimum, the following elements: 1. Priority (acute coronary syndrome, elective, urgent, emergency/salvage); 2. Presence and severity of angina symptoms (e.g., Canadian Cardiovascular Society classification system); 3. Use of antianginal medical therapies within 2 weeks before the procedure, if any; 4. Presence, results, and timing of noninvasive stress test, fractional flow reserve, or intravascular ultrasound, if performed; and 5. Significance of angiographic stenosis (may be quantitative or qualitative) on coronary angiography for treated lesion. 2. 